BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35848478)

  • 21. PIN-like (Ductal) Adenocarcinoma of the Prostate.
    Paulk A; Giannico G; Epstein JI
    Am J Surg Pathol; 2018 Dec; 42(12):1693-1700. PubMed ID: 30138215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variance of Tumor Grade at Radical Prostatectomy With Assessment of Each Tumor Nodule Versus Global Grading.
    Iakymenko OA; Briski LM; Punnen S; Nemov I; Lugo I; Jorda M; Parekh DJ; Gonzalgo ML; Kryvenko ON
    Arch Pathol Lab Med; 2022 Aug; 146(8):1032-1036. PubMed ID: 34752602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Clinical Significance of Perineural Invasion by Prostate Cancer on Needle Core Biopsy: Involvement of Single Versus Multiple Sextant Sites.
    Bell PD; Teramoto Y; Gurung PMS; Numbere N; Yang Z; Miyamoto H
    Arch Pathol Lab Med; 2022 Oct; 146(10):1252-1257. PubMed ID: 35020791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trends in disagreement with outside genitourinary pathology diagnoses at an academic center.
    Taylor C; Puzyrenko A; Iczkowski KA
    Pathol Res Pract; 2022 Aug; 236():153997. PubMed ID: 35780705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating the Outcomes of Active Surveillance in Grade Group 2 Prostate Cancer: Prospective Results from the Canary PASS Cohort.
    Waisman Malaret AJ; Chang P; Zhu K; Zheng Y; Newcomb LF; Liu M; McKenney JK; Brooks JD; Carroll P; Dash A; Filson CP; Gleave ME; Liss M; Martin FM; Morgan TM; Nelson PS; Lin DW; Wagner AA
    J Urol; 2022 Apr; 207(4):805-813. PubMed ID: 34854745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of the Prostate Health Index for detection of prostate cancer: results from a large academic practice.
    Tosoian JJ; Druskin SC; Andreas D; Mullane P; Chappidi M; Joo S; Ghabili K; Agostino J; Macura KJ; Carter HB; Schaeffer EM; Partin AW; Sokoll LJ; Ross AE
    Prostate Cancer Prostatic Dis; 2017 Jun; 20(2):228-233. PubMed ID: 28117387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Percentage of Gleason pattern 4 and tumor volume predict adverse pathological stage and margin status at radical prostatectomy in grade Group 2 and grade Group 3 prostate cancers.
    Iakymenko OA; Lugo I; Briski LM; Nemov I; Punnen S; Kwon D; Pollack A; Stoyanova R; Parekh DJ; Jorda M; Gonzalgo ML; Kryvenko ON
    Prostate; 2021 Sep; 81(12):866-873. PubMed ID: 34184782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Limited Adenocarcinoma of the Prostate on Needle Core Biopsy.
    Bell PD; Teramoto Y; Gurung PMS; Yang Z; Miyamoto H
    Arch Pathol Lab Med; 2022 Apr; 146(4):469-477. PubMed ID: 35020802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Grade Group Underestimation in Prostate Biopsy: Predictive Factors and Outcomes in Candidates for Active Surveillance.
    Audenet F; Rozet F; Resche-Rigon M; Bernard R; Ingels A; Prapotnich D; Sanchez-Salas R; Galiano M; Barret E; Cathelineau X
    Clin Genitourin Cancer; 2017 Dec; 15(6):e907-e913. PubMed ID: 28522288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atypical intraductal proliferation detected in prostate needle biopsy is a marker of unsampled intraductal carcinoma and other adverse pathological features: a prospective clinicopathological study of 62 cases with emphasis on pathological outcomes.
    Shah RB; Nguyen JK; Przybycin CG; Reynolds JP; Cox R; Myles J; Klein E; McKenney JK
    Histopathology; 2019 Sep; 75(3):346-353. PubMed ID: 31012493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of cribriform size, percentage, and intraductal carcinoma in Gleason score 7 prostate cancer with cribriform Gleason pattern 4.
    Chen Z; Pham H; Abreu A; Amin MB; Sherrod AE; Xiao GQ; Aron M
    Hum Pathol; 2021 Dec; 118():18-29. PubMed ID: 34543668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Grade group 2 (10% ≥ GP4) patients have very similar malignant potential with grade group 1 patients, given the risk of intraductal carcinoma of the prostate.
    Kato M; Hirakawa A; Sato H; Hanazawa R; Naito Y; Tochigi K; Sano T; Ishida S; Funahashi Y; Fujita T; Matsukawa Y; Hattori R; Tsuzuki T
    Int J Clin Oncol; 2021 Apr; 26(4):764-769. PubMed ID: 33385274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cribriform morphology predicts upstaging after radical prostatectomy in patients with Gleason score 3 + 4 = 7 prostate cancer at transrectal ultrasound (TRUS)-guided needle biopsy.
    Keefe DT; Schieda N; El Hallani S; Breau RH; Morash C; Robertson SJ; Mai KT; Belanger EC; Flood TA
    Virchows Arch; 2015 Oct; 467(4):437-42. PubMed ID: 26229020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact on the clinical outcome of prostate cancer by the 2005 international society of urological pathology modified Gleason grading system.
    Dong F; Wang C; Farris AB; Wu S; Lee H; Olumi AF; McDougal WS; Young RH; Wu CL
    Am J Surg Pathol; 2012 Jun; 36(6):838-43. PubMed ID: 22592143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computationally Derived Cribriform Area Index from Prostate Cancer Hematoxylin and Eosin Images Is Associated with Biochemical Recurrence Following Radical Prostatectomy and Is Most Prognostic in Gleason Grade Group 2.
    Leo P; Chandramouli S; Farré X; Elliott R; Janowczyk A; Bera K; Fu P; Janaki N; El-Fahmawi A; Shahait M; Kim J; Lee D; Yamoah K; Rebbeck TR; Khani F; Robinson BD; Shih NNC; Feldman M; Gupta S; McKenney J; Lal P; Madabhushi A
    Eur Urol Focus; 2021 Jul; 7(4):722-732. PubMed ID: 33941504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy.
    Savdie R; Horvath LG; Benito RP; Rasiah KK; Haynes AM; Chatfield M; Stricker PD; Turner JJ; Delprado W; Henshall SM; Sutherland RL; Kench JG
    BJU Int; 2012 Jun; 109(12):1794-800. PubMed ID: 21992536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expansile cribriform Gleason pattern 4 has histopathologic and molecular features of aggressiveness and greater risk of biochemical failure compared to glomerulation Gleason pattern 4.
    Greenland NY; Cowan JE; Zhang L; Carroll PR; Chan E; Stohr BA; Simko JP
    Prostate; 2020 May; 80(8):653-659. PubMed ID: 32220141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System.
    Pierconti F; Martini M; Cenci T; Petrone GL; Ricci R; Sacco E; Bassi PF; Larocca LM
    Prostate; 2017 May; 77(6):597-603. PubMed ID: 28144985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of prostate cancer prognostic Gleason grade group using zonal-specific features extracted from biparametric MRI using a KNN classifier.
    Jensen C; Carl J; Boesen L; Langkilde NC; Østergaard LR
    J Appl Clin Med Phys; 2019 Feb; 20(2):146-153. PubMed ID: 30712281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gleason pattern 4 with cribriform morphology on biopsy is associated with adverse clinicopathological findings in a prospective radical prostatectomy cohort.
    Haffner MC; Salles DC; Gao G; Epstein JI
    Hum Pathol; 2020 Apr; 98():74-80. PubMed ID: 32119879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.